# Building Muscle While on a GLP-1 Is Hard—But Possible. This Plan Makes It Much Easier.

GLP-1 receptor agonist medications like semaglutide have revolutionized weight loss treatment, but they create a unique metabolic challenge. Users lose weight rapidly, yet often lose muscle alongside fat. This happens because GLP-1 drugs suppress appetite so effectively that people struggle to consume enough protein to support muscle maintenance and growth.

Women's Health has developed a structured strength plan specifically designed to address this problem. The approach recognizes a core principle: building or preserving muscle on GLP-1 medication requires intentional nutrition and targeted resistance training that counteracts the drug's appetite-suppressing effects.

The strategy centers on three pillars. First, prioritize protein intake at every meal, even when hunger signals diminish. Experts recommend consuming protein-rich foods early in the day when appetite remains highest. Second, perform resistance training three to four times weekly, focusing on compound movements that engage multiple muscle groups. Third, track both weight loss and body composition changes, not just the scale.

The plan accounts for the reality that GLP-1 users often feel full after small meals. This means choosing calorie-dense, protein-rich foods like Greek yogurt, salmon, eggs, and nuts becomes essential. Liquid protein sources like shakes can help when solid food feels overwhelming.

Recovery matters equally. Sleep quality directly impacts muscle protein synthesis, and GLP-1 users should prioritize seven to nine hours nightly. Consistency with strength training prevents the rapid muscle loss that can occur when users rely solely on the medication for weight loss.

Research shows that GLP-1 users who combine medication with structured resistance training preserve significantly more lean muscle mass than those taking medication alone. The effort requires discipline, particularly managing appetite suppression while meeting protein goals. But muscle loss